145 related articles for article (PubMed ID: 2961673)
1. [Analysis of the mechanism of graft-vs-host like disease in [lpr/lpr----+/+] chimera].
Matsunaga T
Hokkaido Igaku Zasshi; 1987 Sep; 62(5):779-89. PubMed ID: 2961673
[TBL] [Abstract][Full Text] [Related]
2. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
Via CS; Sharrow SO; Shearer GM
J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
[TBL] [Abstract][Full Text] [Related]
3. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
Perkins DL; Michaelson J; Glaser RM; Marshak-Rothstein A
J Immunol; 1987 Sep; 139(5):1406-13. PubMed ID: 2887617
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of acute graft-vs-host like reaction in [B6-lpr----B6] spleen chimera mice].
Harada H
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):542-51. PubMed ID: 1427598
[TBL] [Abstract][Full Text] [Related]
5. Lack of transfer of lpr-type abnormalities (lymphoproliferation or lymphoid aplasia) in double congenic nude beige mice engrafted with lpr haematopoietic cells.
Tiberghien F; Pflumio F; Kuntz L; Loor F
Immunology; 1993 May; 79(1):158-66. PubMed ID: 8099566
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation from mutant lpr/lpr mice. Functional abnormalities rather than alloantigenic differences appear to determine the development of a graft-vs.-host-like syndrome.
Allen RD; Marshall JD; Roths JB; Sidman CL
Eur J Immunol; 1990 Sep; 20(9):2057-66. PubMed ID: 2209703
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the mechanism of graft-versus-host-like disease in B6 mice with transferred B6-lpr spleen cells.
Matsunaga T; Kobayashi S; Harada H; Kawaguchi Y; Wang W; Okuyama H
Autoimmunity; 1991; 8(4):307-15. PubMed ID: 1718458
[TBL] [Abstract][Full Text] [Related]
8. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
Thiele DL; Calomeni JA; Lipsky PE
J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
[TBL] [Abstract][Full Text] [Related]
9. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
[TBL] [Abstract][Full Text] [Related]
10. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
Taniguchi K; Gondo H; Nomoto K
J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
12. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific T-cell hyporesponsiveness in MRL congenic mice can be explained by two independent cellular defects.
Waterfield JD; Fairhurst M; Chu R; Levy JG
Immunology; 1987 Jun; 61(2):173-8. PubMed ID: 2954899
[TBL] [Abstract][Full Text] [Related]
14. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
Thiele DL; Bryde SE; Lipsky PE
J Immunol; 1988 Nov; 141(10):3377-82. PubMed ID: 3053897
[TBL] [Abstract][Full Text] [Related]
15. Comparison of wasting syndrome in [MRL lpr/lpr-->MRL +/+] chimera and graft versus host disease in [B10.D2-->BALB/c] chimera and an attempt to transfer the wasting syndrome in [MRL lpr/lpr-->MRL +/+] to MRL +/+ mice.
Aihara M; Aihara Y; Nakajima H
J Dermatol Sci; 1994 Apr; 7(2):107-18. PubMed ID: 7914743
[TBL] [Abstract][Full Text] [Related]
16. Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction.
Pattengale PK; Ramstedt U; Gidlund M; Orn A; Axberg I; Wigzell H
Eur J Immunol; 1983 Nov; 13(11):912-9. PubMed ID: 6641788
[TBL] [Abstract][Full Text] [Related]
17. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
Pals ST; Radaszkiewicz T; Gleichmann E
J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390
[TBL] [Abstract][Full Text] [Related]
18. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
Moser M; Sharrow SO; Shearer GM
J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
[TBL] [Abstract][Full Text] [Related]
19. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
20. Analysis of murine T lymphocyte markers during the early phases of GvH-associated suppression of cytotoxic T lymphocyte responses.
Hurtenbach U; Shearer GM
J Immunol; 1983 Apr; 130(4):1561-6. PubMed ID: 6220057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
